Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Steven Mark Greenberg, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Steven Greenberg and Matthew Frosch.
Connection Strength

5.290
  1. Life imitates art: anti-amyloid antibodies and inflammatory cerebral amyloid angiopathy. Neurology. 2011 Mar 01; 76(9):772-3.
    View in: PubMed
    Score: 0.490
  2. Case records of the Massachusetts General Hospital. Case 22-2010. An 87-year-old woman with dementia and a seizure. N Engl J Med. 2010 Jul 22; 363(4):373-81.
    View in: PubMed
    Score: 0.470
  3. Association Between Immunosuppressive Treatment and Outcomes of Cerebral Amyloid Angiopathy-Related Inflammation. JAMA Neurol. 2020 Oct 01; 77(10):1261-1269.
    View in: PubMed
    Score: 0.238
  4. Hereditary cerebral amyloid angiopathy, Piedmont-type mutation. Neurol Genet. 2020 Apr; 6(2):e411.
    View in: PubMed
    Score: 0.229
  5. Different microvascular alterations underlie microbleeds and microinfarcts. Ann Neurol. 2019 08; 86(2):279-292.
    View in: PubMed
    Score: 0.218
  6. Cerebellar Microbleed Distribution Patterns and Cerebral Amyloid Angiopathy. Stroke. 2019 07; 50(7):1727-1733.
    View in: PubMed
    Score: 0.217
  7. Histopathology of diffusion imaging abnormalities in cerebral amyloid angiopathy. Neurology. 2019 02 26; 92(9):e933-e943.
    View in: PubMed
    Score: 0.212
  8. Emerging concepts in sporadic cerebral amyloid angiopathy. Brain. 2017 Jul 01; 140(7):1829-1850.
    View in: PubMed
    Score: 0.190
  9. Reduced vascular amyloid burden at microhemorrhage sites in cerebral amyloid angiopathy. Acta Neuropathol. 2017 03; 133(3):409-415.
    View in: PubMed
    Score: 0.181
  10. Microbleed and microinfarct detection in amyloid angiopathy: a high-resolution MRI-histopathology study. Brain. 2016 12; 139(Pt 12):3151-3162.
    View in: PubMed
    Score: 0.180
  11. Validation of Clinicoradiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-Related Inflammation. JAMA Neurol. 2016 Feb; 73(2):197-202.
    View in: PubMed
    Score: 0.172
  12. Estimating Total Cerebral Microinfarct Burden From Diffusion-Weighted Imaging. Stroke. 2015 Aug; 46(8):2129-35.
    View in: PubMed
    Score: 0.166
  13. Reducing available soluble ß-amyloid prevents progression of cerebral amyloid angiopathy in transgenic mice. J Neuropathol Exp Neurol. 2012 Nov; 71(11):1009-17.
    View in: PubMed
    Score: 0.138
  14. Modeling intracerebral hemorrhage growth and response to anticoagulation. PLoS One. 2012; 7(10):e48458.
    View in: PubMed
    Score: 0.138
  15. Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann Neurol. 2010 Oct; 68(4):545-8.
    View in: PubMed
    Score: 0.119
  16. MRI markers of small vessel disease in lobar and deep hemispheric intracerebral hemorrhage. Stroke. 2010 Sep; 41(9):1933-8.
    View in: PubMed
    Score: 0.118
  17. Microbleeds versus macrobleeds: evidence for distinct entities. Stroke. 2009 Jul; 40(7):2382-6.
    View in: PubMed
    Score: 0.108
  18. Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann Neurol. 2008 Nov; 64(5):587-91.
    View in: PubMed
    Score: 0.104
  19. A new Thr49Pro transthyretin gene mutation associated with leptomeningeal amyloidosis. J Neurol Sci. 2008 Sep 15; 272(1-2):186-90.
    View in: PubMed
    Score: 0.102
  20. Course of cerebral amyloid angiopathy-related inflammation. Neurology. 2007 Apr 24; 68(17):1411-6.
    View in: PubMed
    Score: 0.094
  21. Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging. J Neurosci. 2007 Feb 21; 27(8):1973-80.
    View in: PubMed
    Score: 0.093
  22. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis. 2006 Dec; 24(3):516-24.
    View in: PubMed
    Score: 0.090
  23. The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Pathol. 2006 Jan; 16(1):30-9.
    View in: PubMed
    Score: 0.086
  24. Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease. J Neuropathol Exp Neurol. 2005 Jul; 64(7):588-94.
    View in: PubMed
    Score: 0.083
  25. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol. 2004 Feb; 55(2):250-6.
    View in: PubMed
    Score: 0.075
  26. Neuropathological correlates of cortical superficial siderosis in cerebral amyloid angiopathy. Brain. 2020 12 05; 143(11):3343-3351.
    View in: PubMed
    Score: 0.060
  27. Histopathology of diffusion-weighted imaging-positive lesions in cerebral amyloid angiopathy. Acta Neuropathol. 2020 05; 139(5):799-812.
    View in: PubMed
    Score: 0.057
  28. In vivo characterization of spontaneous microhemorrhage formation in mice with cerebral amyloid angiopathy. J Cereb Blood Flow Metab. 2021 Jan; 41(1):82-91.
    View in: PubMed
    Score: 0.057
  29. Vasomotion as a Driving Force for Paravascular Clearance in the Awake Mouse Brain. Neuron. 2020 02 05; 105(3):549-561.e5.
    View in: PubMed
    Score: 0.056
  30. Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0. Int J Stroke. 2019 12; 14(9):956-971.
    View in: PubMed
    Score: 0.055
  31. Secondary Bleeding During Acute Experimental Intracerebral Hemorrhage. Stroke. 2019 05; 50(5):1210-1215.
    View in: PubMed
    Score: 0.054
  32. Blood-Brain Barrier Leakage and Microvascular Lesions in Cerebral Amyloid Angiopathy. Stroke. 2019 02; 50(2):328-335.
    View in: PubMed
    Score: 0.053
  33. Cerebral small vessel disease in patients with spontaneous cerebellar hemorrhage. J Neurol. 2019 Mar; 266(3):625-630.
    View in: PubMed
    Score: 0.053
  34. APP Mutations in Cerebral Amyloid Angiopathy with or without Cortical Calcifications: Report of Three Families and a Literature Review. J Alzheimers Dis. 2017; 56(1):37-46.
    View in: PubMed
    Score: 0.046
  35. Microbleeds on MRI are associated with microinfarcts on autopsy in cerebral amyloid angiopathy. Neurology. 2016 Oct 04; 87(14):1488-1492.
    View in: PubMed
    Score: 0.045
  36. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept Validation. JAMA Neurol. 2016 08 01; 73(8):994-1001.
    View in: PubMed
    Score: 0.045
  37. Matrix metalloproteinase 9-mediated intracerebral hemorrhage induced by cerebral amyloid angiopathy. Neurobiol Aging. 2015 Nov; 36(11):2963-2971.
    View in: PubMed
    Score: 0.041
  38. Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage. Alzheimers Dement. 2015 Dec; 11(12):1480-1488.
    View in: PubMed
    Score: 0.041
  39. Cerebral amyloid angiopathy with and without hemorrhage: evidence for different disease phenotypes. Neurology. 2015 Mar 24; 84(12):1206-12.
    View in: PubMed
    Score: 0.040
  40. Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models. Acta Neuropathol. 2013 Sep; 126(3):353-64.
    View in: PubMed
    Score: 0.036
  41. Cerebrovascular lesions induce transient ß-amyloid deposition. Brain. 2011 Dec; 134(Pt 12):3697-707.
    View in: PubMed
    Score: 0.032
  42. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement. 2011 Jul; 7(4):367-85.
    View in: PubMed
    Score: 0.031
  43. Screening for familial APP mutations in sporadic cerebral amyloid angiopathy. PLoS One. 2010 Nov 11; 5(11):e13949.
    View in: PubMed
    Score: 0.030
  44. Differential recognition of vascular and parenchymal beta amyloid deposition. Neurobiol Aging. 2011 Oct; 32(10):1774-83.
    View in: PubMed
    Score: 0.028
  45. Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice. J Neurochem. 2009 Jun; 109(6):1636-47.
    View in: PubMed
    Score: 0.027
  46. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain. 2007 Sep; 130(Pt 9):2310-9.
    View in: PubMed
    Score: 0.024
  47. Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol. 2007 Mar; 64(3):431-4.
    View in: PubMed
    Score: 0.023
  48. Effects of apoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytes. Brain Res. 2006 Sep 21; 1111(1):222-6.
    View in: PubMed
    Score: 0.022
  49. Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease. J Neurosci. 2006 Jan 11; 26(2):365-71.
    View in: PubMed
    Score: 0.021
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.